160 related articles for article (PubMed ID: 22218442)
1. [Childhood adrenocortical tumors: from a clinical to a molecular approach].
Antonini SR; Colli LM; Ferro L; Mermejo L; Castro Md
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):599-606. PubMed ID: 22218442
[TBL] [Abstract][Full Text] [Related]
2. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
3. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract][Full Text] [Related]
4. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
5. Adrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment.
Pinto EM; Rodriguez-Galindo C; Lam CG; Ruiz RE; Zambetti GP; Ribeiro RC
Front Endocrinol (Lausanne); 2021; 12():756523. PubMed ID: 34803919
[TBL] [Abstract][Full Text] [Related]
6. A Diagnostic Approach to Adrenocortical Tumors.
Hodgson A; Pakbaz S; Mete O
Surg Pathol Clin; 2019 Dec; 12(4):967-995. PubMed ID: 31672302
[TBL] [Abstract][Full Text] [Related]
7. Analysis of circulating microRNAs in adrenocortical tumors.
Szabó DR; Luconi M; Szabó PM; Tóth M; Szücs N; Horányi J; Nagy Z; Mannelli M; Patócs A; Rácz K; Igaz P
Lab Invest; 2014 Mar; 94(3):331-9. PubMed ID: 24336071
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.
Wang C; Sun Y; Wu H; Zhao D; Chen J
Histopathology; 2014 Mar; 64(4):567-76. PubMed ID: 24102952
[TBL] [Abstract][Full Text] [Related]
9. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
[TBL] [Abstract][Full Text] [Related]
10. The genetics of adrenocortical tumors.
Espiard S; Bertherat J
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of adrenocortical cancer.
Lehmann T; Wrzesinski T
Cancer Genet; 2012 Apr; 205(4):131-7. PubMed ID: 22559973
[TBL] [Abstract][Full Text] [Related]
12. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
[TBL] [Abstract][Full Text] [Related]
13. Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas.
Creemers SG; van Koetsveld PM; van Kemenade FJ; Papathomas TG; Franssen GJ; Dogan F; Eekhoff EM; van der Valk P; de Herder WW; Janssen JA; Feelders RA; Hofland LJ
Endocr Relat Cancer; 2016 Sep; 23(9):727-37. PubMed ID: 27535174
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenic and diagnostic roles of microRNAs in adrenocortical tumours].
Nagy Z; Decmann Á; Perge P; Igaz P
Orv Hetil; 2018 Feb; 159(7):245-251. PubMed ID: 29429354
[TBL] [Abstract][Full Text] [Related]
15. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
[TBL] [Abstract][Full Text] [Related]
16. ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.
Faillot S; Assie G
Eur J Endocrinol; 2016 Jun; 174(6):R249-65. PubMed ID: 26739091
[TBL] [Abstract][Full Text] [Related]
17. MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors.
Patel D; Boufraqech M; Jain M; Zhang L; He M; Gesuwan K; Gulati N; Nilubol N; Fojo T; Kebebew E
Surgery; 2013 Dec; 154(6):1224-8; discussion 1229. PubMed ID: 24238045
[TBL] [Abstract][Full Text] [Related]
18. SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes.
Letouzé E; Rosati R; Komechen H; Doghman M; Marisa L; Flück C; de Krijger RR; van Noesel MM; Mas JC; Pianovski MA; Zambetti GP; Figueiredo BC; Lalli E
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1284-93. PubMed ID: 22539591
[TBL] [Abstract][Full Text] [Related]
19. A diagnostic approach to adrenal cortical lesions.
McNicol AM
Endocr Pathol; 2008; 19(4):241-51. PubMed ID: 19089656
[TBL] [Abstract][Full Text] [Related]
20. Genomic landscape of paediatric adrenocortical tumours.
Pinto EM; Chen X; Easton J; Finkelstein D; Liu Z; Pounds S; Rodriguez-Galindo C; Lund TC; Mardis ER; Wilson RK; Boggs K; Yergeau D; Cheng J; Mulder HL; Manne J; Jenkins J; Mastellaro MJ; Figueiredo BC; Dyer MA; Pappo A; Zhang J; Downing JR; Ribeiro RC; Zambetti GP
Nat Commun; 2015 Mar; 6():6302. PubMed ID: 25743702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
